|
|
Article: Long-Term Treatment with Inhaled Budesonide in Persons with Mild COPD who Continue Smoking.
- Article from:
- Internal Medicine Alert
- Article date:
- January 15, 2000
CopyrightCOPYRIGHT 2000 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Long-Term Treatment with Inhaled Budesonide in Persons with Mild COPD who Continue Smoking
Abstract & Commentary
Synopsis: This paper outlines the effect of the inhaled steroid budesonide on patients with mild COPD who continue to smoke. Pauwels and colleagues report that there was a significant early (6 months) difference between patients who received the steroid vs. placebo, which then remained throughout the entire trial (3 years). This difference was more marked for those patients who had less than a 36-pack-year smoking history.
Source: Pauwels RA, et al. N Engl J Med 1999;340: 1948-1953.
Chronic obstructive pulmonary disease ...
Related newspaper, magazine, and journal articles:
|
|
Article: FEV, Inc. Announces Cooperation with EIG on Lithium-Ion ...
PR Newswire;
August 17, 2009 ;
700+ words
... ... Cooperation with EIG, Ltd, Will Utilize Capabilities of FEV's Auburn Hills, Michigan Hybrid Electric Vehicle Development ... Center AUBURN HILLS, Mich., Aug. 17 /PRNewswire/ -- FEV, Inc., (FEV) a leading, global developer of advanced powertrain ...
|
|